Sort
82,697 grants matching “vaccine development”
Advanced Development of Vaccines for Infectious Diseases
$2,955,109Uwe Staerz · Greffex, Inc. · N01 · FY2020 · AI
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,954,579Scott M Hammer · Columbia University Health Sciences · UM1 · FY2014 · AI
Accelerated public health and biomedical research on priority public health objectives through collaboration between US NIH and WHO
$2,954,464Martin Friede · World Health Organization · U01 · FY2023 · AI
UAB-MISS MACS/WIHS Combined Cohort Study
$2,954,063Mirjam-Colette Kempf · University Of Alabama At Birmingham · U01 · FY2022 · HL
Center for AIDS Research
$2,952,749James A Hoxie · University Of Pennsylvania · P30 · FY2014 · AI
Clinical Trials Units for NIAID Networks (UM1)
$2,952,539Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2014 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,950,624Stephen C Harrison · Boston Children'S Hospital · P01 · FY2025 · AI
Task V05: Development of Assays and Reagents for Coronavirus Vaccines
$2,950,261Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
North Carolina Seronet Center for Excellence
$2,950,055Ralph S Baric · Univ Of North Carolina Chapel Hill · U54 · FY2023 · CA
The Immunobiology of Marrow Allografts for Leukemia
$2,949,927Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2006 · CA
HPV Vaccine Trial
$2,949,855Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$2,949,775Ted Ross · University Of Georgia · N01 · FY2024 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$2,949,775Ted Ross · University Of Georgia · N01 · FY2024 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$2,949,775Ted Ross · University Of Georgia · N01 · FY2024 · AI
Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys
$2,948,233Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
SPORE IN BREAST CANCER
$2,948,038University Of Alabama At Birmingham · P50 · FY2002 · CA
Strategies for Eliciting bnAbs against Conserved HIV-1 Quaternary Epitopes
$2,947,908Abraham Pinter · Rbhs-New Jersey Medical School · P01 · FY2014 · AI
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$2,947,202Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2013 · AI
SPORE in Skin Cancer
$2,946,962Brigham And Women'S Hospital · P50 · FY2004 · CA
Center for AIDS Research
$2,946,696Ronald G Collman · University Of Pennsylvania · P30 · FY2017 · AI
University of Pennsylvania HIV Clinical Trials Unit
$2,946,326Ian Frank · University Of Pennsylvania · UM1 · FY2024 · AI
PHRU-Setshaba Clinical Trials Unit
$2,946,297Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2025 · AI
SPORE IN BREAST CANCER
$2,944,585Johns Hopkins University · P50 · FY2004 · CA
Understanding resistance and tolerance to nitroimidazoles in Mycobacterium tuberculosis
$2,944,529Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Case AIDS Clinical Trials Unit
$2,944,131Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2013 · AI